The global neuropathic pain treatment market is estimated to grow at a CAGR of nearly 5.8% during the forecast period. The major factors contributing to the growth of the market include increasing prevalence of diabetes and rising incidences of spinal cord injury. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. As of 2019, the estimated number of individuals suffering from spinal cord injury in the US is nearly 291,000. Nearly 78% of new incidences were reported among males.